StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Kesimpta Global Growth in Constant Currencies by Quarter

Kesimpta Global Growth in Constant Currencies (% cc) (%)

QuarterlyAnnual

Novartis Kesimpta Global Growth in Constant Currencies: 22.0% in Q3 2026, down 22.0 pts from a year earlier. That is the lowest of the 17 quarters on record here.

Latest, Q3 2026
22.0%
Period ended Sep 30, 2026
Change on a year earlier
-22.0 pts
44.0% in Q3 2025
History
17 quarters
Since Q3 2022
Sources
17
Documents cited below

Where the Q3 2026 figure comes from

“|| Kesimpta | 1 484 | 1 222 | 21 | 22”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedKesimpta Global Growth in Constant Currencies (% cc) (%)Year on yearSource
Q3 2026Sep 30, 202622.0%-22.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202632.0%-1.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202626.0%-17.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202527.0%-22.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202544.0%+16.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202533.0%-32.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202543.0%-23.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202449.0%-24.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202428.0%-96.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202465.0%-40.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202466.0%-34.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202373.0%-84.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023124.0%-48.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023105.0%–Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023100.0%–Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022157.0%–Novartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Kesimpta Global Growth in Constant Currencies (%), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-kesimpta-yoy-cc-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.